Michael David Rabinoff ^1*, Nicholas Caskey ², Anthony Rissling ³, Candice Park ⁴

¹ Dept of Psychiatry and Biobehavioral Science, UCLA
² UCLA/WLAVA
³ USC/UCLA
⁴ UCLA

^* To whom correspondence should be addressed. E-mail: mrabinoff{at}mednet.ucla.edu.

	Abstract

We investigated tobacco industry documents and other sources for evidence of possible pharmacological and chemical effects of tobacco additives.

Our findings indicated that more than 100 of 599 documented cigarette additives have pharmacological actions that camouflage the odor of environmental tobacco smoke emitted from cigarettes, enhance or maintain nicotine delivery, could increase the addictiveness of cigarettes, and mask symptoms and illnesses associated with smoking behaviors.

Whether such uses were specifically intended for these agents is unknown. Our results provide a clear rationale for regulatory control of tobacco additives.

Key Words: Health Law, Health Policy, Environmental Tobacco Smoke, Smoking Cessation, Tobacco Control, Tobacco